|
| NB: The information displayed below does not replace the protocol. The latest protocol version should always be consulted before making clinical decisions. |
|
SRN002 (PERFORM)
|
|
SRN002
|
|
|
Topic
|
|
Stroke
|
|
Portfolio Eligibility
|
|
UKCRN adopted, commercial study
|
|
|
|
|
Study Type |
Interventional
|
|
Design Type |
Treatment
|
|
Disease(s) |
Drug type
|
|
Phase |
III
|
|
|
Current Status
| Closed - in follow-up |
| |
|
Sample Size
| 18000 |
|
|
Lead Country
| Scotland (also active in England and Northern Ireland and Wales) |
|
|
Main Inclusion Criteria
|
|
None specified
|
|
|
Main Exclusion Criteria
|
|
None specified
|
|
|
Chief Investigator(s)
|
| Prof Kennedy Lees |
|
|
Further details, please contact
|
Ms Emma Fountain
Servier Laboratories Ltd
Wexham Springs
Framewood Road
Slough
SL3 6RJ
UNITED KINGDOM
Tel: 01753 666459
emma.fountain@uk.netgrs.com
|
|
|
Funder(s) |
Servier Laboratories Ltd
|
|
Sponsor(s) |
|
|
|
|